CAPRICOR THERAPEUTICS, INC.

Profile

Company Names

CAPRICOR THERAPEUTICS, INC.
NILE THERAPEUTICS, INC.

Addresses

8840 WILSHIRE BLVD 2ND FLOOR, BEVERLY HILLS, CA 90211

8840 WILSHIRE BLVD., 2ND FLOOR, BEVERLY HILLS, CA 90211

8840 WILSHIRE BLVD, 2ND FLOOR, BEVERLY HILLS, CA 90211

4 WEST 4TH AVE, SUITE 400, SAN MATEO, CA 94402

115 SANSOME STREET, SUITE 310, SAN FRANCISCO, CA 94104

Phone Numbers

(310) 358-3200
650-458-2670
415-875-7880

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$51,940,905.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2017-05-09 
$3,708,503.00 
$3,708,503.00 
$0.00 
Equity 
7
2016-03-16 
$13,974.00 
$13,974.00 
$0.00 
 
6
2015-02-06 
$7,050,001.00 
$7,050,001.00 
$0.00 
Equity 
5
2015-01-21 
$10,002,028.00 
$10,002,028.00 
$0.00 
Equity 
4
2014-02-10 
$32,676.00 
$32,676.00 
$0.00 
Equity 
3
2013-11-20 
$26,289,973.00 
$26,289,973.00 
$0.00 
Equity 
2
2011-06-20 
$2,500,000.00 
$2,500,000.00 
$0.00 
Equity 
1
2009-07-07 
$2,343,750.00 
$2,975,000.00 
$631,250.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DEBORAH 
 
ASCHEIM 
EXECUTIVE OFFICER
ARIE 
S. 
BELLDEGRUN 
DIRECTOR
ANTHONY 
 
BERGMANN 
EXECUTIVE OFFICER
RICHARD 
B. 
BREWER 
EXECUTIVE OFFICER, DIRECTOR
EARL 
 
COLLIER 
DIRECTOR
EARL 
 
COLLIER, JR. 
DIRECTOR
ANTHONY 
 
DAVIES 
EXECUTIVE OFFICER
DARON 
 
EVANS 
EXECUTIVE OFFICER
LELAND 
 
GERSHELL 
EXECUTIVE OFFICER
PEDRO 
 
GRANADILLO 
DIRECTOR
LOUIS 
 
GRASMICK 
DIRECTOR
ANDREW 
 
HAMER 
EXECUTIVE OFFICER
PETER 
M. 
KASH 
DIRECTOR
JOSHUA 
KAZAM 
EXECUTIVE OFFICER, DIRECTOR
JOSHUA 
A. 
KAZAM 
EXECUTIVE OFFICER, DIRECTOR
KAREN 
 
KRASNEY 
EXECUTIVE OFFICER
HSIAO 
D. 
LIEU 
EXECUTIVE OFFICER
LOUIS 
 
MANZO 
DIRECTOR
LINDA 
 
MARBAN 
EXECUTIVE OFFICER, DIRECTOR
PAUL 
A. 
MIEYAL 
DIRECTOR
PAUL 
A. 
MIEYAL, PH.D. 
DIRECTOR
DAVID 
 
MUSKET 
DIRECTOR
GREGORY 
 
SCHAFER 
DIRECTOR
GREGORY 
W. 
SCHAFER 
DIRECTOR
RACHEL 
 
SMITH 
EXECUTIVE OFFICER
DAVID 
M. 
TANEN 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-09 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2016-03-16 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-02-06 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2015-01-21 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-10 
D
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2013-11-20 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-06-20 
D
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
NO REVENUES 
Equity 
2009-07-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SC+H CAPITAL
NONE
NONE
H.C. WAINWRIGHT + CO., LLC
375
NONE
NONE
SC+H CAPITAL
RIVERBANK CAPITAL SECURITIES, INC.
RIVERBANK CAPITAL SECURITIES, INC.
LADENBURG THALMANN + CO., INC.
505
LADENBURG THALMANN + CO., INC.
505
RIVERBANK CAPITAL SECURITIES, INC.
RIVERBANK CAPITAL SECURITIES, INC.